Atomoxetine
Atomoxetine
Atomoxetine (pronounced /ˌætəˈmɒksɪtiːn/), also known by its brand name Strattera, is a norepinephrine reuptake inhibitor (NRI) used primarily in the treatment of attention deficit hyperactivity disorder (ADHD).
Etymology
The term "Atomoxetine" is derived from the combination of the words "atom" and "oxetine". The "atom" part of the name is a reference to the atomic structure of the drug, while "oxetine" is a common suffix used in the names of selective serotonin reuptake inhibitors (SSRIs), a class of drugs that Atomoxetine is closely related to.
Usage
Atomoxetine is used to treat ADHD in children, adolescents, and adults. It works by increasing the levels of norepinephrine, a neurotransmitter in the brain that helps with focus and attention.
Side Effects
Common side effects of Atomoxetine include nausea, vomiting, insomnia, fatigue, and decreased appetite. More serious side effects can include suicidal ideation, liver damage, and heart disease.
Related Terms
- Norepinephrine reuptake inhibitor (NRI)
- Attention deficit hyperactivity disorder (ADHD)
- Norepinephrine
- Suicidal ideation
- Liver damage
- Heart disease
External links
- Medical encyclopedia article on Atomoxetine
- Wikipedia's article - Atomoxetine
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski